Digital Medicine

Digital Medicine

In 2012, the Scripps Translational Science Institute (STSI) established a Division of Digital Medicine, which has developed into an internationally recognized leader in all aspects of the clinical implementation of wireless technologies in health and healthcare. Our mission is to guide innovation and the transformation of medicine that has been made possible through the availability of digital technologies.  We are accomplishing this through the generation of the high quality knowledge needed to inform the medical community and the public to drive change.

Quell® Opioid Reduction and Pain Relief in Patients with Cancer

This clinical study will assess the impact of Quell wearable pain relief technology on opioid use and pain in cancer patients.

mHealth Screening To Prevent Strokes

The mHealth Screening To Prevent Strokes (mSToPS) trial is a home-based clinical research study that uses wearable sensor technology to identify people with asymptomatic atrial fibrillation (AFib).

Sensor Technology and Analytics to Monitor, Predict, and Protect Ebola Patients

This proof-of-concept study used wearable, wireless health sensors, a wireless vital sign monitoring platform, and advanced analytics technology to monitor and analyze multiple vital signs of patients either suspects or confirmed to be infected with the Ebola virus.

Wired for Health

The Scripps Wired for Health Study aims to evaluate the impact of using a smartphone enabled “Wireless Monitoring System” in conjunction with a disease wellness and prevention program on the healthcare costs and resource utilization of chronically ill individuals with diabetes, hypertension, and cardiac arrhythmia.

Essential Tremor & Parkinson’s Disease

The aim of the Genetic & Digital Diagnosis of Essential Tremor & Parkinson’s Disease (GAGDET-PD) trial is to determine whether essential tremor, a benign tremor disorder, and Parkinson’s Disease, a neurodegenerative disorder, can be differentiated via combined genetic testing and monitoring of tremors with a wristwatch-like accelerometer device.

Genomic Risk Markers for Atrial Fibrillation Following Cardiac Rhythm Monitoring

The Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Monitoring (GIRAFFE) study is designed to determine whether genetic risk scores for AFib can identify individuals at high risk of undiagnosed AFib.

Big Data

In partnership with organizations such as Walgreens and Withings, STSI is exploring some of the largest patient-generated datasets in the world to better understand how people make use of activity trackers, health-monitoring devices, and smartphone apps to improve their health.

Physician Mental Health

Physician burnout is of growing concern. This study aims to track individual physician mood states using a set of 3 digital health smartphone devices and assessing if these metrics track with validated mood state surveys.

Pilot Study of the MultiSense Patch to Record Cardiopulmonary Data during Sleep and Wake Cycles

This proof-of-concept study uses the MultiSense™ wearable device, developed by Rhythm Diagnostic Systems, to explore its diagnostic capabilities in individuals suspected of having obstructive sleep apnea.

Reduction of Cost through Immediate Access to High Quality Lumify Smart Device Ultrasound

The Philips Lumify smart device ultrasound allows physicians to conduct ultrasound procedures at the bedside, potentially reducing the number of standard radiologic ultrasounds ordered, and thereby reducing associated costs. This study surveys physician satisfaction with the Lumify device, including ease of use.

Scanadu Scout™ Study

STSI is conducting a prospective observational study to evaluate the real-world use of Scanadu Scout™, an wireless electronic device designed to measure vital signs in seconds.

There remains enormous untapped potential to do more to lead the transformation of health and health care. STSI intends to help lead that transformation by generating high quality knowledge around digital technology, and through the training of the first generation of digital health scholars.

Steven Steinhubl, MD

Director, Digital Medicine